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INTRODUCTION
Systemic lupus erythematosus (SLE) is one of the most un-
predictable systemic connective tissue diseases. Headache is
a common symptom in SLE patients (1-3) but whether there
is a unique syndrome attributable to SLE is not clear. Dif-
ferent types of headache may occur in SLE due to various un-
derlying conditions. Pseudotumor cerebri (PC) is an uncommon
syndrome of neuropsychiatric SLE and one of the causes of
headache in SLE patients. In 1968 Bettman et al. (4) first
reported a patient with concomitant SLE and PC. Since then
PC has been reported in a few sporadic cases in adult patients
with SLE (5, 6). However, recurrent PC in patients with SLE,
which has been reported rarely (7-11), has not been report-
ed in Korea.
Here, we describe a 30-yr-old female patient with SLE who
was afflicted with recurrent PC. This case illustrates that the
possibility of PC should be taken into account in the differ-
ential diagnosis of headache during the course of SLE.
CASE REPORT
A 30-yr-old woman was referred to our department due
to intractable headache, dizziness, fatigue, nausea and vom-
iting. She had been well until two weeks before admission,
when she experienced severe frontal headache. The severity
of her headache increased over one week prior to admission.
She was diagnosed with SLE five year earlier in accord with
the ACR criteria (12): malar rash, arthritis, photosensitivity,
thrombocytopenia (85,000/ L), and positive results for anti-
nuclear antibody (1:320, speckled pattern), anti-dsDNA, and
anti-Ro antibodies. She had symptoms of elevated intracranial
pressure: headache, diplopia, nausea and vomiting. Ophthal-
mologic examination showed bilateral papilledema and the
findings of brain CT scan was normal. A lumbar puncture
produced clear acellular cerebrospinal fluid (CSF) with an
opening pressure above 300 mmH2O. Treatment with pred-
nisolone 60 mg/day was started on the basis of a diagnosis of
PC associated with SLE. After 3 months of treatment, relief
of the signs and symptoms with normal CSF opening pres-
sure. She had been well for the next five year with low dose
prednisolone and hydroxychloroquine (300 mg/day) until her
headache recurred.
At the current admission, her vital signs were body tem-
perature of 37.7℃, blood pressure of 100/60 mmHg, pulse
rate of 79/min, and respiration rate of 17/min. A faint and
pink maculopapular rash was noted over the face. No palpa-
ble lymph nodes were noted. An ophthalmologic examina-
tion revealed bilateral papilledema but visual acuity and
visual fields were normal. Neurological examination was
normal.
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Recurrent Pseudotumor Cerebri in Systemic Lupus Erythematosus
: A Case Report
Pseudotumor cerebri is an uncommon manifestation of neuropsychiatric sys-
temic lupus erythematosus (SLE), and is characterized by an elevated intracra-
nial pressure, papilledema with occasional abducens nerve paresis, absence of
a space-occupying Iesion or ventricular enlargement, and normal cerebrospinal
fluid chemical and hematological constituents. Pseudotumor cerebri has been
reported in a few sporadic cases in patients with systemic lupus erythematosus.
However, the recurrent pseudotumor cerebri in patients with systemic lupus ery-
thematosus which has been rarely reported, has not been reported in Korea.
We experienced a 30-yr-old female patient with SLE who was presented with
second attack of severe intractable headache. She was diagnosed pseudotu-
mor cerebri  twice and successfully treated with corticosteroid. Headache is the
common symptom in patients with neuropsychiatric SLE and attributable to vari-
ous causes. We suggest that it is important to define the cause of headache in
patients with SLE and pseudotumor cerebri should be included in the spectrum
of clinical manifestations during the course of SLE as a cause of headache.
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Laboratory results showed a white blood cell count of
3,200/ L, hemoglobin of 9.1 g/dL, reticulocytosis of 1.1%,
and platelet count of 235,000/ L. Erythrocyte sedimenta-
tion rate (ESR) was 80 mm/hr. Serum electrolytes, liver and
kidney function test results were normal. Coagulation test
results were normal, with prothrombin time of 100% (INR
1.0), activated partial thromboplastin time of 38.0 sec (nor-
mal, 29.8-41.8). Immunoglobulin profiles demonstrated an
elevated level of IgG upto 1,810 mg/dL (normal, 751-1,560)
and normal levels of IgA and IgM. Antinuclear antibody
titer was 1:640 (speckled pattern) and anti-dsDNA anti-
body was 114 IU/mL (normal, <7). Anti-Ro, anti-RNP
tests were both positive. Complement levels were decreased:
C3, 60.9 mg/dL (normal, 65-125) and C4, 7.19 mg/dL (nor-
mal, 12-43). Tests for anticardiolipin antibody (IgG, IgM)
and lupus anticoagulant were negative. Hormonal profile
showed normal levels of TSH, free T3, T4, FSH, LH, estro-
gens, progesterone, prolactin, and cortisol.
A lumbar puncture showed clear acellular CSF with an
opening pressure of above 280 mmH2O (normal, <60-160
mmH2O) and glucose and protein concentrations of 30.6
mg/dL (normal, 15-45) and 62 mg/dL (normal, 50-75), re-
spectively. CSF bacteria cultures and tests for viral antibody
of varicella-zoster, herpes simplex, influenza A, B, cytome-
galovirus, adenovirus, and Epstein-Barr virus were all nega-
tive. The findings of brain magnetic resonance images were
normal (Fig. 1).
The patient was diagnosed with recurrent PC represent-
ing as a flare-up of neuropsychiatric SLE. Treatment with
prednisolone 60 mg daily and azathioprine 100 mg/day was
started, and subsequently the prednisolone was tapered by
dose to 10 mg/day over 8 weeks. After three months of fol-
low-up, the patient’ s signs and symptoms were noted to be
relieved.
DISCUSSION
Neuropsychiatric SLE includes the neurologic syndromes
of the central, peripheral, and autonomic nervous system
and psychiatric syndromes observed in patients with SLE
after excluding other causes. Since the first report of stupor
and coma in SLE by Hera and Kaposi (13) in 1875, a mul-
titude of neuropsychiatric syndromes have been reported in
SLE patients. Neuropsychiatric affliction in SLE has become
well established with a frequency of as high as 14 to 75%
(14), and PC has been reported in a few cases of adult patients
with neuropsychiatric SLE (5, 6).
Diagnosis of PC requires increased intracranial pressure
(CSF pressure >200 mmH2O) without clinical, laboratory,
or radiological evidence of a space-occupying lesion or hydro-
cephalus. This patient fulfilled all of these criteria for PC.
The patient manifested the symptoms and signs suggesting
increased intracranial pressure as intractable headache, nausea,
vomiting and bilateral papilledema. The increased intracra-
nial pressure was determined by lumbar puncture during
which opening pressure of CSF showed above 280 mmH2O.
The chemical and hematological compositions of the CSF
were normal. The last criterion was satisfied by the absence
of radiological abnormalities in findings of MRI scan.
Although PC is known to be associated with various con-
ditions, the etiology of the disease is unknown. In addition,
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Fig. 1. Brain MRI images (T1-weighted sagittal and T2-weighted axial) show normal sized ventricle and subarachnoid space without
space-occupying lesion.
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diverse therapeutic agents, including vitamin A, tetracycline,
nalidixic nitrofurantoin, sulfa derivatives, lithium, pheny-
toin and indomethacin, have been used in this disorder. The
systemic conditions of PC are primarily endocrinological
abnormalities such as hypo- and hyperthyroidism, hypopara-
thyroidism, adrenal insufficiency, Cushing’ s syndrome and
oral contraceptives. Pregnancy, obesity (particularly among
women), anemia, hypertension and rare cases of sarcoidosis
were reported to be associated with PC (15). SLE is one of
the enlisted diseases underlying PC, albeit not common (5-
11, 14-19).
The following conditions rendered it reasonable think that
SLE was attributable to PC in this patient: she did not have
menstrual irregularities or endocrinopathies; she was not on
contraceptive pills, antibiotics or vitamins, which are known
to induce PC. Corticosteroid therapy could not be implicat-
ed because this patient was receiving only low dose of pred-
nisolone at the time of diagnosis of PC.
The pathophysiologic mechanism of PC in SLE remains
unknown. It is not clear whether the overproduction of CSF,
relative absorptive failure of CSF, or increased cerebral blood
flow is associated with the pathogenesis of PC in SLE (16).
On the other hand, PC in SLE has been attributed to cere-
bral venous thrombosis in some cases. The patients in these
cases had lupus anticoagulant or anticardiolipin antibodies
that were assumed to induce a hypercoagulable state that
eventuated in cerebral venous thrombosis (6, 9, 17). Thro-
mbotic obliteration of the arteriolar or venous vascular bed
might have affected the arachnoid villi and eventually have
caused PC in this patient. However, vasculitis, immune com-
plex precipitation or even direct antibody injury may all
result in a similar dysfunction (11). In this patient, the test
for serum anticardiolipin antibody and lupus anticoagulant
test were negative and evidence of sagittal or other venous
or arterial thromboses was not demonstrated in MRI scans.
The laboratory and radiological findings along with the grad-
ual onset and progression of PC-related symptoms in this
patient favored the latter hypothesis as a causative condition.
SLE-associated PC usually indicates a favorable outcome.
The most critical sequela of PC is the permanent visual im-
pairment. In a recent prospective study (18), a large propor-
tion of patients were found to have some visual loss includ-
ing blind spot enlargement in at least one eye on follow-up.
Furthermore, recurrent PC (7-11), chronic low-grade papil-
ledema, and death from progressive renal disease have been
observed in some patients (19). Corticosteroid is currently
the mainstay of the treatment of PC in patients with SLE
(19), and acetazolamide, intravenous mannitol and furosemide
are also used. In addition, plasmapheresis, azathioprine, cyclo-
phosphamide and other immunosuppressive agents can be
used in the treatment of such patients.
In conclusion, we described a 30-yr-old female patient with
SLE who presented with second attack of severe intractable
headache. She was diagnosed recurrent PC, as a neuropsy-
chiatric SLE. Headache is the commonest symptom encoun-
tered in patients with neuropsychiatric SLE and is attributable
to different syndromes. It is important to define the cause of
headache in patients with SLE, since there is no typical pattern
in the benign headache of lupus. Although the underlying
mechanisms of the cerebral manifestations are not always
readily identifiable, we suggest that PC should be included
in the spectrum of neuropsychiatric manifestations during
the course of SLE.
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